Center for Scientific Review; Amended Notice of Meeting, 67370 [2013-26894]
Download as PDF
<![CDATA[
emcdonald on DSK67QTVN1PROD with NOTICES
67370
Federal Register / Vol. 78, No. 218 / Tuesday, November 12, 2013 / Notices
15]; or (B) the date on which the
Secretary of Health and Human Services
lists any vaccines against seasonal
influenza (other than any vaccine
against seasonal influenza listed by the
Secretary prior to the date of the
enactment of this Act) for purposes of
compensation for any vaccine-related
injury or death through the Vaccine
Injury Compensation Trust Fund.’’
Public Law 113–15, § 1. The law further
provides that if the vaccines were sold
before or on the effective date of the
excise tax, but delivered after this date,
the delivery date of such vaccines shall
be considered the sale date. Id.
Under this statutory language, the
effective date of the excise tax for
seasonal influenza vaccines other than
trivalent influenza vaccines is the later
of August 1, 2013 (which is the first day
of the first month beginning more than
4 weeks after the effective date of Public
Law 113–15, which was June 25, 2013),
or the date on which the Secretary
publishes a notice of coverage under the
VICP for seasonal influenza vaccines not
previously covered under the VICP.
This publication is the notice referred to
in the latter requirement. Because this
publication is made after August 1,
2013, the effective date of coverage for
all vaccines against seasonal influenza
(beyond trivalent influenza vaccines,
which are already covered by the VICP)
is the effective date of this publication,
November 12, 2013.
Petitions filed concerning vaccinerelated injuries or deaths associated
with all vaccines against seasonal
influenza vaccines must be filed within
the applicable statute of limitations. The
filing limitations applicable to petitions
filed with the VICP are set out in section
2116(a) of the PHS Act (42 U.S.C.
300aa–16(a)). In addition, section
2116(b) of the PHS Act lays out specific
exceptions to these statutes of
limitations that apply when the effect of
a revision to the Table makes a
previously ineligible person eligible to
receive compensation or when an
eligible person’s likelihood of obtaining
compensation significantly increases.
Under this provision, persons who may
be eligible to file petitions based on the
addition of a new category of vaccines
under Category XVII of the Table may
file a petition for compensation not later
than 2 years after the effective date of
the revision if the injury or death
occurred not more than 8 years before
the effective date of the revision of the
Table (42 U.S.C. 300aa–16(b)). Thus,
persons whose petitions may not be
timely under the limitations periods
described in section 2116(a) of the PHS
Act, may still file petitions concerning
vaccine-related injuries or deaths
VerDate Mar<15>2010
17:41 Nov 08, 2013
Jkt 232001
associated with seasonal influenza
vaccines (with the exception of trivalent
influenza vaccines that are already
covered under the VICP) until
November 12, 2015, as long as the
vaccine-related injury or death occurred
on or before November 12, 2021 (8 years
prior to the effective date of the addition
of non-trivalent seasonal influenza
vaccines as covered vaccines).
The Table will be amended through
subsequent rulemaking to include all
vaccines against seasonal influenza in
place of only trivalent influenza
vaccines under Category XIV of the
Table. Once that is done, the Table’s
coverage provisions (codified at 42 CFR
100.3(c)) will explain that trivalent
influenza vaccines are included on the
Table as of July 1, 2005, and that other
seasonal influenza vaccines are
included on the Table as of November
12, 2013.
Dated: November 5, 2013.
Mary K. Wakefield,
Administrator.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, October 10, 2013, 09:00
a.m. to October 10, 2013, 03:00 p.m.,
National Institutes of Health, 6700 B
Rockledge Drive, 3137, Bethesda, MD,
20892 which was published in the
Federal Register on September 16, 2013,
78 FR 56904.
The meeting notice is amended to
change the date of the meeting from
October 10, 2013 to December 5, 2013.
The meeting is closed to the public.
Dated: November 5, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26906 Filed 11–8–13; 8:45 am]
[FR Doc. 2013–26992 Filed 11–8–13; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Virology—A Study
Section, October 03, 2013, 08:30 a.m. to
October 04, 2013, 05:30 p.m., Embassy
Suites Baltimore—Downtown, 222 St.
Paul Place, Baltimore, MD which was
published in the Federal Register on
September 17, 2013, 78 FR 180 Pgs.
57169–57170.
The meeting will start on December
16, 2013 at 9:00 a.m. and end December
17, 2013 at 5:00 p.m. The meeting
location remains the same. The meeting
is closed to the public.
Dated: November 5, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26894 Filed 11–8–13; 8:45 am]
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
National Institutes of Health
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; Heart, Lung, and
Blood Program Project Review Committee.
Date: December 6, 2013.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Jeffrey H Hurst, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA National Heart, Lung, and
Blood Institute, National Institutes of Health,
6701 Rockledge Drive, Room 7208, Bethesda,
E:\FR\FM\12NON1.SGM
12NON1
]]>Agencies
[Federal Register Volume 78, Number 218 (Tuesday, November 12, 2013)]
[Notices]
[Page 67370]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26894]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Virology--
A Study Section, October 03, 2013, 08:30 a.m. to October 04, 2013,
05:30 p.m., Embassy Suites Baltimore--Downtown, 222 St. Paul Place,
Baltimore, MD which was published in the Federal Register on September
17, 2013, 78 FR 180 Pgs. 57169-57170.
The meeting will start on December 16, 2013 at 9:00 a.m. and end
December 17, 2013 at 5:00 p.m. The meeting location remains the same.
The meeting is closed to the public.
Dated: November 5, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-26894 Filed 11-8-13; 8:45 am]
BILLING CODE 4140-01-P
